Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

Our industry-leading litigation practice regularly represents the world’s largest branded pharmaceutical companies in high-stakes, high-risk litigation. Drug makers trust our litigators to handle their blockbuster Hatch-Waxman, BPCIA, and competitor litigation matters because they possess the unique combination of technical, legal, and industry expertise necessary for success.

Examples of our biotechnology and pharmaceutical work include:

  • Patenting groundbreaking life sciences innovations, including tissue engineering, therapeutic agents and methods, antibodies, and genetically engineered animals
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting IP due diligence on billions of dollars in deal value for pharmaceutical investments, mergers, and acquisitions
  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Litigating ANDA cases on behalf of branded pharmaceuticals
  • Representing biotechnology and pharmaceutical companies in post-grant proceedings at the PTAB, as well as coordinating post-grant and district court litigation strategies

Notable Wins

Fish Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead

Fish won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of litigation and business misconduct constituting “unclean hands.”

Read more about this precedential opinion here and here.

Fish Wipes Out $2.5B Patent Verdict Against Gilead Sciences

Fish & Richardson won a motion for Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict against its client Gilead Sciences Inc. in federal court in Delaware.

Read about this historic win here and here.

Recent Webinars

2021

2020

2019

2018

Mayo/Myriad Tracker

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
Event
April 5th, 2021 | 2:20 pm EDT
Longwood Healthcare Leaders Spring Meeting
Speaking Engagement
Sponsorship
News
March 12, 2021
Fish & Richardson Principal Frank Scherkenbach Admitted to American College of Trial Lawyers
Press Release
Recognition
News
News
March 8, 2021
Fish Attorneys Author Biosimilar Development Article, "Regulatory And Legislative Actions Set The Tone For Biosimilars In 2021"
Articles
News
Event
February 23rd, 2021 | 8:00 am CET
C5 13th Annual Pharma & Biotech Patent Litigation in Europe
Speaking Engagement
Conference/Convention
News
January 26, 2021
Kurt Glitzenstein Quoted in The American Lawyer "Litigation Leaders" Article
Media Mention
News
News
January 7, 2021
Fish & Richardson Receives 2020 “Attorney of the Year” Group Award from Minnesota Lawyer
Press Release
Recognition
News
News
January 5, 2021
Fish & Richardson Elevates Its Most Diverse Principal Class Ever
Press Release
News
Event
January 28th, 2021 | 1:30 pm EST
Webinar | Biosimilars - 2020 Year in Review
Webinar
Event
January 27th, 2021 | 1:30 pm EST
Life Sciences Webinar Series | 2020 Year in Review
Webinar
Event
December 10th, 2020 | 11:40 am PST
21st Annual Berkeley-Stanford Advanced Patent Law Institute (APLI)
Speaking Engagement
Conference/Convention
Event
December 3rd, 2020 | 10:30 am EST
Xconomy: Xcelerating Life Sciences - New York & Philadelphia
Speaking Engagement
Conference/Convention
Sponsorship
Event
December 5th, 2020 | 8:00 am EST
Chinese Antibody Society (CAS): Revisiting the Perspectives of Bispecific Antibodies under the COVID-19 Pandemic
Speaking Engagement
Sponsorship
load more topics